Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Back to team page
Kristen Kauphusman
Director
Kristen’s background resides within psychology and cognitive neuroscience. She has 7 years of experience working in consumer neuroscience research, where she applied a diverse set of neuroscience tools (EEG, eye tracking, facial coding, and biometrics) to clients’ complex business objectives. Her diverse experience and technical understanding of the human brain allows Kristen to assist clients by applying a unique lens to all research problems. Kristen has a BS in Psychology with an emphasis in Neuropsychology at University of Wisconsin, La Crosse.
Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?

You cannot start the day without doing this...
Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Do you have a long-term personal or professional goal you'd like to share?
Read our team’s latest bold insights
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.